Speaker Profile

MBA, RAC, Vice President, Head of Translational Sciences & Diagnostics, BMS

Biography
Sarah has more than 20 years of industry experience in leading R&D organizations, CLIA and GLP laboratories, device manufacturing, consortiums, assessment and implementation of technology strategies, and development of in vitro diagnostics. In addition, she continuously works to further education and awareness in Precision Medicine and Companion Diagnostic spaces. Prior to joining BMS, Sarah was the Vice President, Precision Medicine & Companion Diagnostics for Celgene, where she founded their Precision Medicine Organization in 2016. She joined Celgene after having held the position as the Global Head of Future Precision Medicine for Novartis, where the team submitted and gained approval for multiple Health Authority applications; including the first pre-market approval for a distributable NGS CDx.Sarah has also held multiple roles with increasing responsibility within Johnson and Johnson (JNJ) including Global Head of Operations, Assay Program Leader for Companion Diagnostics Center of Excellence, Director of Materials Process Development and Enabling Technologies.


 Session Abstract – PMWC 2023 Silicon Valley

Track 3 - January 25 9.00 A.M.-4.15 P.M.


Track Chair: Hakan Sakul, Pfizer

  • PMWC Award Ceremony:
    Honoree: Todd Golub, Broad Institute
  • Fireside Chat: Precision Medicine: Past, Present and Future
    - Todd Golub, Broad Institute
    - Hakan Sakul, Pfizer
  • Challenges in Providing Global Access to Precision Health (PANEL)
    Chair: Mike Pellini, Section32
    - Peter Kuhn, USC
    - Steven Rosen,
    - Sarah Hersey, BMS
    - Ed Abrahams, PMC
  • Regulatory and Reimbursement Challenges for Precision Medicines (PANEL)
    Chair: Cynthia Bens, PMC
    - Robert Dumanois, ThermoFisher
    - Kaska Kowanetz, Pfizer
    - Sarah Hersey, BMS
    - Elaine Katrivanos, Tempus
    - Elizabeth Mansfield, Foundation Medicine
  • Early Cancer Detection 360 Degree View
    Chair: Christian Wolfrum, Siemens Healthineers
    - Christian Eusemann, Siemens Healthineers
  • Novel Clinical Trial Designs (PANEL)
    Chair: Razelle Kurzrock, Medical College of Wisconsin
    - Jim Palma, Target Cancer Foundation
    - Corrie Painter, TBA
  • Expanding Precision Medicine into Non-Traditional Settings
    - Ed Kim, City of Hope
  • Equity in Delivery of Precision Cancer Care through Community-Academic Partnerships
    - Manali Patel, Stanford
  • Challanges in Genomic Profiling of Pediatric Cancers
    - Andrew Kung, MSK
    - Christina Curtis, Stanford
  • PMWC NCI Showcase
    - Solomon Diamond, Lodestone
    - Jennifer Smith, PreCyte